Retacrit Injectable
Retacrit is a veterinary-use formulation of epoetin alfa, a synthetic erythropoiesis-stimulating agent that promotes red blood cell production. It is commonly used under veterinary supervision to help manage anemia, particularly in animals with chronic kidney disease. This injectable medication supports improved oxygen-carrying capacity and overall vitality in affected pets.
Giving your pet an injection might feel intimidating at first, but with practice, it becomes routine. Follow these steps for safe and stress-free injections.
Get Your Supplies Ready
- Medication vial or pre-filled syringe
- Alcohol swabs
- Sterile syringe & needle (if not pre-filled)
- Sharps container for safe needle disposal
Drawing Up the Dose (if needed)
- Clean the vial top with an alcohol swab
- Attach needle to syringe
- Pull in air equal to the dose
- Insert needle into vial, push air in
- Draw out the correct dose
- Tap out air bubbles
Pick the Injection Site
- Subcutaneous (under the skin): Loose skin between shoulder blades or side
- Intramuscular (into muscle): As directed by your vet
Prep the Area
- Pinch a fold of skin to form a “tent” (for subcutaneous). Wipe with alcohol if recommended.
Inject the Medication
- Hold the syringe like a pencil
- Insert the needle into the base of the skin tent at a 45° angle
- Push the plunger slowly to inject
After the Injection
- Remove the needle smoothly
- Place it immediately in the sharps container (don’t recap)
- Pat the area and give your pet praise or a treat
Safety Tips
- Never reuse needles
- Always dispose of used needles properly
- Ask your vet for help if unsure
Epoetin alfa-epbx, commercially available as Retacrit, is an erythropoiesis-stimulating agent (ESA) utilized for managing red blood cell production. It is a prescription injectable available for use in multiple species, frequently considered by veterinarians in the context of kidney health for managing anemia associated with chronic renal failure.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
At a pharmacological level, it manages the production of red blood cells by mimicking the body's natural erythropoietin signaling. Commonly observed effects include behavioral shifts such as lethargy or localized changes at the injection site. A significant clinical consideration is the potential for the body to develop antibodies against the medication; your veterinarian will monitor for observational signs of sensitivity through regular blood work. Owners should monitor for significant changes in activity or appetite.
Yes. Retacrit is a prescription injectable medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before dispensing.
Veterinarians discuss Retacrit because compromised kidneys stop producing enough erythropoietin. This may be considered in the context of managing red blood cell levels and supporting energy during recovery.
Your veterinarian will recommend frequent blood tests (CBC or PCV) to monitor red blood cell counts and iron levels. This monitoring ensures the management approach remains safe.
Yes, Retacrit is frequently considered for both dogs and cats presented with renal-related anemia. Your veterinarian will determine the appropriate dose based on your pet's diagnostic findings.
Weakness can be an observational sign of anemia or a shift in blood pressure. If you notice your pet appearing unusually lethargic, contact your veterinarian immediately for a clinical review.
